AI digital twin developer Twin Health announced that it brought in a $53 million investment round, led by Maj Invest of ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

A unique research opportunity rounded out Brevin St. Onge’s undergraduate education at Central Michigan University, and the ...

People with type 2 diabetes treated with GLP-1 receptor agonists may face a slightly higher risk for eye complications ...

Diabetes risk factors, especially overweight/obesity, are common among household members of adult patients with prediabetes.

The creators of the world-first app at diagnostics company PocDoc say the test could also save the NHS billions ...

Currently, stem cells and transplants are reserved for people whose diabetes cannot be controlled by the standard treatments.

GLP-1RAs were associated with a reduced risk for neurodegenerative and cerebrovascular diseases in type 2 diabetes and obesity.

More than half of adults and more than one-third of children living in the same home as another adult with prediabetes have ...

Researchers believe they've made a significant step forward in preventing type 1 diabetes, by demonstrating how a pancreatic ...

Novo Nordisk's economic moat is eroding due to increased competition and US drug price pressures, but growth in international ...